FXAIX | LEVOX | FXAIX / LEVOX | |
Total Expense Ratio | 0.01 | 1.10 | 1% |
Annual Report Gross Expense Ratio | 0.01 | 1.11 | 1% |
Fund Existence | 14 years | 20 years | - |
Gain YTD | 1.498 | -8.068 | -19% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 594B | 46.8M | 1,269,231% |
Annual Yield % from dividends | 1.34 | 0.25 | 534% |
Returns for 1 year | 13.10 | -57.61 | -23% |
Returns for 3 years | 59.34 | -76.99 | -77% |
Returns for 5 years | 116.74 | -74.78 | -156% |
Returns for 10 years | 205.44 | -72.98 | -282% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ECHSX | 12.77 | N/A | N/A |
Eaton Vance Worldwide Health Sci C | |||
VTCIX | 152.07 | N/A | N/A |
Vanguard Tax-Managed Capital App I | |||
MNMRX | 14.47 | N/A | N/A |
Manning & Napier Pro-Blend Mod Term R | |||
JANRX | 18.76 | -0.19 | -1.00% |
Janus Henderson Global Select D | |||
WALSX | 13.65 | -0.31 | -2.22% |
Wasatch Long/Short Alpha Investor |